Read The Vajenda with Scottie
Keep The Vajenda. Lose the inbox pileup.
Scottie reads the newsletters you choose, keeps the useful differences, and attaches every original link. The Vajenda stays in your reading life without becoming another email to manage.
An independent guide. Scottie isn't affiliated with, endorsed by, or sponsored by The Vajenda. The publication owns its name, writing, and subscription terms.
From Scottie · July 31, 2026
See The Vajenda in a Scottie brief
Scottie read The Vajenda, The Female Edge, and Ground Truths for a reader with the priorities shown below. Start with the rundown, open the full brief, or check every issue behind it.
3sources
28issues read
6stories included
4 of 5 The Vajenda issues included
What shaped this brief
Reader priorities
A patient or clinician who wants evidence-led explanations of menopause, hormone therapy, metabolism, and gynecologic care.
These are illustrative priorities, not a customer’s data.
Sources in this brief
- The VajendaThe publication this guide is about
- The Female EdgeAdds the lived midlife questions around sexuality, hormones, and nervous-system symptoms.
- Ground TruthsAdds broader medical research and critical analysis of health trends.
Scottie
Scottie example brief
July 31, 2026 · Executive brief
01 / The rundown
- Telemedicine claims regarding female testosterone deficiency clash with international medical guidelines that reject routine diagnostic blood testing for women.
- Clinical consensus supports hormone therapy for menopausal symptom relief while cautioning against unproven claims regarding dementia and cardiovascular prevention.
- A new two-year clinical study evaluates how proactive management of fat distribution shifts and lipid changes during perimenopause improves cardiometabolic health.
Read the complete brief 6 stories · 3 action items
02 / The briefing
01 / main
Telemedicine Claims Face Scrutiny Over Female Testosterone Deficiency
The takeaway: Telemedicine platform MIDI markets testosterone cream for female deficiency claims like fatigue and brain fog. Medical guidelines confirm no established low-testosterone cutoff or clinical syndrome exists for women, making blood testing unhelpful for diagnosis.
Concrete details
- 80% of postmenopausal women in a US study showed testosterone levels below 30 ng/dL.
- A 2019 review of 810 postmenopausal women found no psychological well-being benefit from testosterone.
Why it matters for this reader: For clinicians and patients evaluating menopause protocols, understanding evidence-based androgen guidelines helps separate marketing claims from genuine evidence-backed therapies.
Original sourcesThe Vajenda
02 / main
Menopause Hormone Therapy Reclaims Its Place Beyond The Hype
The takeaway: Following the Women's Health Initiative, hormone therapy was widely underprescribed due to safety concerns. While it remains effective for hot flashes and bone density, current evidence does not support using it to prevent dementia or heart disease.
Concrete details
- Over 80% of women with moderate-to-severe symptoms do not seek medical care for menopause.
- Research shows at least 50% of perimenopausal women already have a chronic medical condition.
Why it matters for this reader: As a clinician or patient navigating hormone care, knowing where clinical trials end and marketing exaggeration begins protects you against overpromised treatments.
Original sourcesThe Vajenda
03 / main
Menopause Metamorphosis Shifts Fat Distribution And Lipids Fast
The takeaway: Menopause involves accelerated cardiometabolic changes, including abdominal fat accumulation and elevated LDL cholesterol. A new two-year clinical trial is testing whether structured, guideline-based medical care during perimenopause improves long-term cardiovascular and metabolic outcomes.
Concrete details
- The study enrolls 200 participants across three university trial locations to evaluate preventive care.
- Trial monitoring includes monthly telehealth visits and three in-person clinical evaluations.
Why it matters for this reader: This clinical trial highlights why tracking metabolic markers like lipids and blood pressure alongside reproductive hormones is vital for personalized midlife healthcare.
Original sourcesThe Vajenda
04 / main
Postmenopausal Endometrial Findings Require Careful Clinical Evaluation
The takeaway: Bleeding and a proliferative endometrium during hormone replacement indicate an imbalance where estrogen exposure exceeds progestogen protection. While benign, active cell growth in postmenopausal tissue requires clinical evaluation and management to prevent long-term endometrial risks.
Concrete details
- Healthy postmenopausal endometrial tissue without hormone therapy is expected to be entirely atrophic.
- Proliferative findings reflect active cell growth caused by relative estrogen dominance.
Why it matters for this reader: For clinicians monitoring hormone regimens or patients experiencing unscheduled bleeding, recognizing proliferative tissue as a signal to adjust progestogen dosage is essential for safe care.
Original sourcesThe Vajenda
05 / main
Rethinking Postmenopausal Vaginal Health and Long-Term Function
The takeaway: Standard medical training historically viewed postmenopausal vaginal tissue decline as an irreversible end to sexual health. Modern evidence supports proactive restoration using targeted protocols including local hormone support, microbiome optimization, and non-hormonal therapies.
Concrete details
- The protocol combines four primary treatment components and eight supporting tools for tissue responsiveness.
- Active management focuses on maintaining blood flow, estrogen levels, and healthy bacterial balance.
Why it matters for this reader: This evidence-backed framework gives clinicians and patients actionable protocols to maintain tissue health and sexual function across midlife rather than accepting unmanaged decline.
Original sourcesThe Female Edge
06 / main
Diagnostic Framing Refreshes Focus on Irregular Cycles and Hyperandrogenism
The takeaway: Diagnostic approaches for Polyendocrine Metabolic Ovarian Syndrome highlight classic presentations like irregular menstrual cycles and hyperandrogenism signs. Clarifying the metabolic and endocrine dimensions helps identify clinical patterns like missed periods and hirsutism sooner.
Concrete details
- Clinical cases often present with menstrual delays stretching from five weeks to four months.
- Hyperandrogenism symptoms frequently include coarse jawline hair, periareolar hair, and cystic acne.
Why it matters for this reader: Understanding the metabolic and endocrine drivers of cycle irregularity and androgen excess helps you apply precise diagnostic criteria in gynecologic care.
Original sourcesThe Female Edge
Action items
- Review hormone therapy guidelines to separate proven symptom treatments from unverified dementia or cardioprotective claims.
- Assess baseline lipid panels and blood pressure during midlife clinical evaluations to catch early cardiometabolic changes.
- Evaluate progestogen dosage adequacy whenever postmenopausal patient spot-bleeding or proliferative endometrial results occur.
See every issue behind this brief
Telemedicine Claims on Female Testosterone Deficiency
- MIDI and the Making of Female Testosterone DeficiencyThe Vajenda · Included
Historical Controversies in Menopause Hormone Therapy
- Why Did a Reasonable Menopause Article Cause So Much Outrage?The Vajenda · Included
Rethinking Postmenopausal Vaginal Tissue Restoration
- I Don’t Believe Your Vagina Has an Expiration DateThe Female Edge · Included
Metabolic and Lipid Changes During Menopause Care
- What Happens When Women ACTUALLY Get State-of-the-Art Medical Care in Menopause?The Vajenda · Included
PMOS labs and treatment
- The PMOS Prescription Nobody Explains: Labs, Lifestyle, Metformin, and What a GLP-1 Costs Your Muscle and EnergyThe Female Edge · Read, not included
Reframing PCOS as Polyendocrine Metabolic Ovarian Syndrome
Evaluating Unexpected Bleeding on Hormone Therapy
- Bleeding on Menopause Hormone Therapy and a Proliferative EndometriumThe Vajenda · Included
founder monthly QA
- July 2026 Founder's Q&AThe Female Edge · Read, not included
female anatomy education
- The Sexual Education You Didn’t GetThe Female Edge · Read, not included
optimized hormone labs
- Turning It Off to Turn It OnThe Female Edge · Read, not included
female pleasure communication
- Reclaiming Pleasure: An Evidence-Based Path for WomenThe Female Edge · Read, not included
endometriosis diagnostic tests
- A New Era for Endometriosis Diagnosis?The Vajenda · Read, not included
blood mercury and thyroid
- How Much Mercury Is Too Much for a Woman?The Female Edge · Read, not included
breast implant considerations
- She Spent Years Being Told Nothing Was Wrong. Nobody Asked About Her Implants.The Female Edge · Read, not included
mental load physical symptoms
- The Cost of Being All Things to All PeopleThe Female Edge · Read, not included
female desire biology
- Your Hormones Got Ruled Out. Your Nervous System Never Got Tested.The Female Edge · Read, not included
orgasmic meditation study
- Science Studied Orgasmic Meditation. I Was One of the Researchers.The Female Edge · Read, not included
biological aging clocks
- Medicine is Moving From Calendars to ClocksGround Truths · Read, not included
vaginal microbiome disclosure
- What Bryan Johnson Accidentally Got RightThe Female Edge · Read, not included
orgasm frequency statistics
- No More FakingThe Female Edge · Read, not included
couples therapy practices
- The Weekly Practice That Made Me Feel Safer with My Partner Than 10 Years of Couples Therapy Ever DidThe Female Edge · Read, not included
nervous system patterns
- The Body I Learned to IgnoreThe Female Edge · Read, not included
- She Read Every Room Before She Read Her Own Body. So Did I.The Female Edge · Read, not included
high functioning dissociation
- Are You Dissociated? I Was.The Female Edge · Read, not included
tumor microenvironment blood test
- Aaron Newman: A Breakthrough Blood Test for CancerGround Truths · Read, not included
AI in life science
- Patrick Hsu: How Is AI Catalyzing Life Science?Ground Truths · Read, not included
psychedelic assisted therapy
- I Am the Canary in the Coal Mine. So Are One in Four Women You Know.The Female Edge · Read, not included
marriage repair strategies
- 7 Ways to Repair a Marriage Worth SavingThe Female Edge · Read, not included
About The Vajenda
Should you add The Vajenda to Scottie?
Make sense of menopause and women's-health claims through current clinical evidence.[1][2][3]
Who it’s for
A patient or clinician who wants evidence-led explanations of menopause, hormone therapy, metabolism, and gynecologic care.[1][2]
What you’ll find in it
The issues linked below include “Menopause, Menopause Hormone Therapy, Metabolism, and Weight Gain/Loss”, “Why Did a Reasonable Menopause Article Cause So Much Outrage?”, and “What Happens When Women ACTUALLY Get State-of-the-Art Medical Care in Menopause?”. Open them to judge the publication in its own words.
- Byline
- Dr. Jen Gunter[1]
How to read The Vajenda with Scottie
Add its public feed for publicly available issues. If you subscribe to paid issues, forward those emails to your private @scottie.fyi address. Scottie does not need access to your inbox.
Scottie read 5 The Vajenda items and included 4 for the brief. The sources covered different things, so Scottie kept their stories separate instead of forcing a connection.
Read three issues from The Vajenda
Read the publication in its own words. Scottie keeps these original links attached; it does not replace the writing.
Sources and official links
- The Vajenda official publication and public archive
- Menopause, Menopause Hormone Therapy, Metabolism, and Weight Gain/Loss
- Why Did a Reasonable Menopause Article Cause So Much Outrage?
- What Happens When Women ACTUALLY Get State-of-the-Art Medical Care in Menopause?
- The Female Edge official publication
- Ground Truths official publication